Back to search

Article

Construction of Probiotic Escherichia coli Nissle 1917 as a Next- Generation Expression Platform and Its Application in Therapeutic Protein Production

2025-09-19

Abstract excerpt

<title>Abstract</title> <p> Biologics produced in <italic>Escherichia coli</italic> BL21(DE3) require rigorous removal of lipopolysaccharide (LPS), also termed endotoxin, as its presence can elicit severe immune responses and life threatening complications in humans. <italic>Escherichia coli</italic> Nissle 1917 (EcN) is a clinically approved probiotic with unique biosafety characteristics due to its LPS-def...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
b55845cc-b140-5a9e-a7eb-5e6bc86ff923
DOI
10.21203/rs.3.rs-7512809/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Construction of Probiotic Escherichia coli Nissle 1917 as a Next- Generation Expression Platform and Its Application in Therapeutic Protein ProductionDOI 10.21203/rs.3.rs-7512809/v1
Select a neighboring publication to make it the new centre.